United States · Series C startup
One round we have observed, with the 8 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Raised 2 months ago
Follow AusperBio Therapeutics and see its new rounds in your feed. Start following
Funding summaryUpdated 5 Nov 2026
$120Mraised across 1 round since 2026, from 3 sources
Harbert Growth PartnersLead
Qiming Venture Partners
RA Capital Management
CDH Investments
Sherpa Capital
Hankang Capital
InnoPinnacle FundReported by TechStartups and 2 others
Missing a round, or an investor who was in one? Tell us.
AusperBio Therapeutics's investors include Harbert Growth Partners, Qiming Venture Partners, RA Capital Management, CDH Investments and Sherpa Capital, and 3 more on record. Harbert Growth Partners led its latest round.
AusperBio Therapeutics has raised $120M across 1 round since 2026.
AusperBio Therapeutics's most recent round was a Series C of $120M in Aug 2026, led by Harbert Growth Partners.
Its most recent round, $120M in Aug 2026, is also its largest on record.
AusperBio Therapeutics's first round on record, in Aug 2026, was backed by Harbert Growth Partners, Qiming Venture Partners and RA Capital Management and 5 others.
AusperBio Therapeutics's latest named round is a Series C, in Aug 2026.
AusperBio Therapeutics is based in the United States.
Harbert Growth Partners led the Series C in 2026.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
